0.15Open0.15Pre Close2 Volume944 Open Interest10.00Strike Price30.00Turnover39.80%IV11.17%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier23DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type0.2037Delta0.3087Gamma91.30Leverage Ratio-0.0058Theta0.0011Rho18.60Eff Leverage0.0065Vega
MiMedx Stock Discussion
I want more, pls go down for a minute
In a recent move that underscores their confidence in the regenerative medicine sector, Mizuho Securities has maintained its 'Buy' rating on MiMedx Group Inc. (NASDAQ: MDXG) and has raised the price target from a previous estimate to $14. This comes as the company continues to make significant strides in its advanced wound care and surgical tissue solutions. $MiMedx (MDXG.US)$